JP2019518026A5 - - Google Patents
Info
- Publication number
- JP2019518026A5 JP2019518026A5 JP2018563619A JP2018563619A JP2019518026A5 JP 2019518026 A5 JP2019518026 A5 JP 2019518026A5 JP 2018563619 A JP2018563619 A JP 2018563619A JP 2018563619 A JP2018563619 A JP 2018563619A JP 2019518026 A5 JP2019518026 A5 JP 2019518026A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- crystal
- crystals
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2016/084300 | 2016-06-01 | ||
| CNPCT/CN2016/084300 | 2016-06-01 | ||
| PCT/CN2017/086760 WO2017206924A1 (zh) | 2016-06-01 | 2017-06-01 | 抑制蛋白激酶活性化合物的晶型及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518026A JP2019518026A (ja) | 2019-06-27 |
| JP2019518026A5 true JP2019518026A5 (https=) | 2022-03-15 |
| JP7054528B2 JP7054528B2 (ja) | 2022-04-14 |
Family
ID=60477983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563619A Active JP7054528B2 (ja) | 2016-06-01 | 2017-06-01 | プロテインキナーゼ活性を抑制する化合物の結晶形態、及びその適用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10899744B2 (https=) |
| EP (1) | EP3470410B1 (https=) |
| JP (1) | JP7054528B2 (https=) |
| KR (1) | KR102466958B1 (https=) |
| CN (1) | CN109195964B (https=) |
| AU (1) | AU2017274110B2 (https=) |
| CA (1) | CA3026142C (https=) |
| EA (1) | EA201892687A1 (https=) |
| ES (1) | ES2981015T3 (https=) |
| IL (1) | IL263356B (https=) |
| MY (1) | MY188379A (https=) |
| PH (1) | PH12018502529A1 (https=) |
| PL (1) | PL3470410T3 (https=) |
| RU (1) | RU2744264C2 (https=) |
| SG (1) | SG11201810800VA (https=) |
| TW (1) | TWI646094B (https=) |
| WO (1) | WO2017206924A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113861191B (zh) | 2018-06-21 | 2023-09-19 | 贝达药业股份有限公司 | 抑制cdk4/6活性化合物的晶型及其应用 |
| WO2022031636A1 (en) | 2020-08-03 | 2022-02-10 | Teva Pharmaceuticals International Gmbh | Solid state forms of ensartinib and ensartinib salts |
| EP4385510A4 (en) * | 2021-08-10 | 2025-08-20 | Betta Pharmaceuticals Co Ltd | USE OF ENSARTINIB OR A CORRESPONDING SALT IN THE TREATMENT OF A DISEASE CARRYING A MET EXON 14 SKIPPING MUTATION |
| KR102851417B1 (ko) * | 2022-08-16 | 2025-08-28 | 제이투에이치바이오텍 (주) | 피리미딘-4-카복사마이드 화합물의 결정형 및 이를 포함하는 경구용 약학 제제 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2002002643A0 (en) | 2000-03-06 | 2002-12-31 | Warner Lambert Co | 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| DK1603570T5 (da) | 2003-02-26 | 2013-12-09 | Sugen Inc | Aminoheteroarylforbindelser som proteinkinaseinhibitorer |
| US8414489B2 (en) | 2003-11-13 | 2013-04-09 | Medtronic Minimed, Inc. | Fabrication of multi-sensor arrays |
| ES2355923T3 (es) * | 2004-08-26 | 2011-04-01 | Pfizer, Inc. | Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa. |
| EP1786777A1 (en) | 2004-08-26 | 2007-05-23 | Pfizer, Inc. | Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| DK1963302T3 (da) | 2005-12-05 | 2013-04-02 | Pfizer Prod Inc | Polymorfer af en C-MET/HGFR-inhibitor |
| CN101652068A (zh) * | 2007-01-19 | 2010-02-17 | 艾科睿制药公司 | 激酶抑制物化合物 |
| JP5670325B2 (ja) | 2008-06-19 | 2015-02-18 | エックスカバリー ホールディング カンパニー エルエルシー | キナーゼ阻害化合物としての置換されたピリダジンカルボキサミド化合物 |
| CA2813580C (en) * | 2010-10-08 | 2017-12-05 | Xcovery Holding Company, Llc | Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| PL2625176T3 (pl) | 2010-10-08 | 2017-08-31 | Xcovery Holding Company Llc | Podstawione związki 6-amino-pirydazyn-3-ylo-karboksyamidu jako modulatory kinazy białkowej |
-
2017
- 2017-05-31 TW TW106117900A patent/TWI646094B/zh active
- 2017-06-01 SG SG11201810800VA patent/SG11201810800VA/en unknown
- 2017-06-01 ES ES17805869T patent/ES2981015T3/es active Active
- 2017-06-01 AU AU2017274110A patent/AU2017274110B2/en active Active
- 2017-06-01 KR KR1020187038142A patent/KR102466958B1/ko active Active
- 2017-06-01 EA EA201892687A patent/EA201892687A1/ru unknown
- 2017-06-01 EP EP17805869.9A patent/EP3470410B1/en active Active
- 2017-06-01 PL PL17805869.9T patent/PL3470410T3/pl unknown
- 2017-06-01 CN CN201780006852.3A patent/CN109195964B/zh active Active
- 2017-06-01 RU RU2018145183A patent/RU2744264C2/ru active
- 2017-06-01 IL IL263356A patent/IL263356B/en unknown
- 2017-06-01 WO PCT/CN2017/086760 patent/WO2017206924A1/zh not_active Ceased
- 2017-06-01 JP JP2018563619A patent/JP7054528B2/ja active Active
- 2017-06-01 US US16/306,104 patent/US10899744B2/en active Active
- 2017-06-01 CA CA3026142A patent/CA3026142C/en active Active
- 2017-06-01 MY MYPI2018002245A patent/MY188379A/en unknown
-
2018
- 2018-11-29 PH PH12018502529A patent/PH12018502529A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102510855B (zh) | N-[3-氟-4-({6-(甲基氧基)-7-[(3-吗啉-4-基丙基)氧基]-喹啉-4-基}氧基)苯基]-n′-(4-氟苯基)环丙烷-1，1-二甲酰胺的晶形 | |
| TW201617347A (zh) | 一種ｊａｋ激酶抑制劑的硫酸氫鹽的結晶形式及其製備方法 | |
| JP2019518026A5 (https=) | ||
| JP2018520178A (ja) | プリナブリン組成物 | |
| CN111164085B (zh) | 瑞博西林的共晶和瑞博西林单琥珀酸盐的共晶、其制备方法、组合物和用途 | |
| WO2018184185A1 (zh) | 奥扎莫德加成盐晶型、制备方法及药物组合物和用途 | |
| CN105324375A (zh) | 盐酸尼洛替尼的多晶型形式 | |
| WO2015139591A1 (zh) | 德罗格韦钠盐的晶型及其制备方法 | |
| JP2019531323A (ja) | （ｒ）−４−ヒドロキシ−２−オキソ−１−ピロリジンアセトアミドの結晶型、調製方法、用途 | |
| RU2018145183A (ru) | Кристаллическая форма соединения, подавляющего активность протеинкиназы, и её применение | |
| WO2018103027A1 (zh) | 替吡法尼的晶型及其制备方法及药物组合物 | |
| CN111247153B (zh) | 3-(5-氟苯并呋喃-3-基)-4-(5-甲基-5H-[1，3]间二氧杂环戊烯并[4，5-f]吲哚-7-基)吡咯-2，5-二酮的固体形式 | |
| CN114685431B (zh) | 一种阿昔替尼柠檬酸盐晶型 | |
| WO2019195569A1 (en) | Solid-state forms of abemaciclib, their use and preparation | |
| WO2003045953A1 (en) | Crystals of taxane derivative and process for their production | |
| CN116120341A (zh) | Gdc-0077的晶型及其制备方法和用途 | |
| TW201734023A (zh) | 溫諾平(vinorelbine)單酒石酸鹽及其藥學用途 | |
| US7777049B2 (en) | Crystalline forms of Rizatriptan benzoate | |
| JP2018510173A (ja) | トピロキソスタットの新規結晶形及びその製造方法 | |
| CN114685492B (en) | Crystal form of TAS-116, preparation method, pharmaceutical composition and application thereof | |
| CN105294808B (zh) | 醋酸乌利司他晶g型物质及制备方法和其组合物与用途 | |
| WO2023202651A1 (en) | Polymorphic forms of glutamine antagonist and uses thereof | |
| EP3710425A1 (en) | Solid state forms of elafibranor | |
| CN113943270B (zh) | 一种阿昔替尼晶型 | |
| CN113943271B (zh) | 一种阿昔替尼晶型及其制备方法 |